Biopharm Co. Seelos Gets OK For Credit Bid In July Auction
A New York bankruptcy judge on Wednesday gave biopharmaceutical company Seelos Therapeutics approval for a July asset auction with a $22 million baseline credit bid, over the objections of unsecured creditors...To view the full article, register now.
Already a subscriber? Click here to view full article